|
|
Article: Biotech, Pharma Companies Continue Refining Relationships.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Washington Editor
WASHINGTON - Most CEOs, researchers and investors in the drug and biologics industry would agree that often it takes 100 ideas to find one or two drugs that actually work.
So in this highly competitive field, how's a small biotechnology company supposed to get the attention of a large pharmaceutical firm when it comes time to find a partner?
Representatives from three large pharmaceutical companies - AstraZeneca Pharmaceuticals LP, of London; Merck & Co. Inc., of Whitehouse Station, N.J.; and Hoffmann-La Roche Inc., of Nutley, N.J. - answered that question in various ways Tuesday during the opening session of the BioWindover ...
Related newspaper, magazine, and journal articles:
|